News

Dyadic and IIBR Team Up to Fight COVID-19

The partners will explore Dyadic’s C1 gene expression platform in conjunction with IIBR’s express gene sequences and targets to develop a potential vaccine candidate and monoclonal antibodies.
/ read more /

Eurofins DiscoverX Grants Bioassay Certification to VelaLabs

Eurofins DiscoverX partners with VelaLabs to enable VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP conditions.
/ read more /

ERS Genomics, Aelian Biotechnology in CRISPR/Cas9 License Agreement

Under the agreement, ERS Genomics will license its gene-editing technology to Aelian Biotechnoloy to support its commercial functional genomic screening platform.
/ read more /

Strategic Investor Agrees to Develop Solvias

Water Street Healthcare Partners, a strategic investor that is focused on the healthcare industry, has agreed to invest in Solvias, a global pharmaceutical laboratory services business.
/ read more /

CPhI Japan Postponed Amid Novel Coronavirus Outbreak

The decision was made after it was determined that many of the event’s largest stakeholders would be unable to travel to the conference due to the novel coronavirus outbreak.
/ read more /

FDA Responds to Coronavirus Outbreak

The agency is taking steps to monitor the supply chain and assist in the development of treatments.
/ read more /

The Native Antigen Company Releases Covid-19 Antigens

The Native Antigen Company has commercially introduced antigens that have been specifically derived from the Wuhan strain of novel coronavirus, now named Covid-19.
/ read more /

Horizon Discovery Licenses Knockout CHO Cell Line to NGM Biopharmaceuticals

The knockout CHO K1 cell line will be used to support biotherapeutic R&D across a range of therapeutic indications.
/ read more /